LivaNova (LIVN) Operating Income (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60% |
| Dec 31, 2025 | -21.17% |
| Sep 30, 2025 | -0.32% |
| Jun 30, 2025 | 11.45% |
| Mar 31, 2025 | 31.32% |
| Dec 31, 2024 | 3.94% |
| Sep 30, 2024 | -11.32% |
| Jun 30, 2024 | 147.24% |
| Mar 31, 2024 | 118.46% |
| Dec 31, 2023 | -2,073.76% |
| Sep 30, 2023 | -74.34% |
| Jun 30, 2023 | 841.93% |
| Mar 31, 2023 | -116.78% |
| Dec 31, 2022 | 110.58% |
| Sep 30, 2022 | -515.58% |
| Jun 30, 2022 | 234.10% |
| Mar 31, 2022 | -61.60% |
| Dec 31, 2021 | 50.74% |
| Sep 30, 2021 | 145.29% |
| Jun 30, 2021 | -536.40% |
| Mar 31, 2021 | 97.71% |
| Dec 31, 2020 | -3,197.44% |
| Sep 30, 2020 | 54.89% |
| Jun 30, 2020 | -2,781.76% |
| Mar 31, 2020 | 99.60% |
| Dec 31, 2019 | -658.89% |
| Sep 30, 2019 | 186.23% |
| Jun 30, 2019 | -43.78% |
| Mar 31, 2019 | 92.48% |
| Dec 31, 2018 | -4,702.01% |
| Sep 30, 2018 | -126.64% |
| Jun 30, 2018 | 72.44% |
| Mar 31, 2018 | -33.85% |
| Dec 31, 2017 | -36.90% |
| Sep 30, 2017 | 8.09% |
| Jun 30, 2017 | 40.65% |
| Mar 31, 2017 | 232.75% |
| Dec 31, 2016 | -148.97% |
| Sep 30, 2016 | 21.40% |
| Jun 30, 2016 | 375.72% |
| Oct 18, 2015 | -223.94% |
| Jul 24, 2015 | 27.16% |